Navigation Links
Kendle Named Best CRO for Second Consecutive Year by Leading Global Pharmaceutical Publication Scrip
Date:12/12/2007

Company's ability to build and maintain successful partnerships, patient recruitment expertise and its global reach cited as reasons for selection

CINCINNATI, Dec. 12 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization (CRO), today announced it was named "Best CRO" at the Scrip Awards held Dec. 4 in London. Kendle was selected from among leading global CROs by a distinguished panel of pharmaceutical industry executives. The annual awards competition, organized by Scrip World Pharmaceutical News, a leading provider of news and analysis for the global biopharmaceutical industry, is designed to recognize new standards of excellence and celebrate achievements that reflect cutting-edge science and the intellectually exciting and socially rewarding nature of the industry. This is the second year in a row Kendle has received the "Best CRO Award."

(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO )

"Kendle is honored to be recognized once again by the Scrip expert panel as 'Best CRO'," noted Candace Kendle, PharmD, Chairman and Chief Executive Officer. "In a service business it's all about people, and at Kendle our associates offer exceptional qualities that make a real difference to our customers."

According to Scrip World Pharmaceutical News, "The judges felt that among Kendle's strengths are its ability to build and maintain successful partnerships, its global reach, patient recruitment expertise, its skills in core therapeutic areas as well as niche areas and its extensive pregnancy registry."

Selection criteria for the award included performance across multiple categories, including range of capabilities, exceeding sponsor expectations, ability to build solid long-term working relationships within biopharmaceutical companies, quality of data management and innovative strategies for regulatory guidance. In their deliberations, the judges looked at the range of services provided by the entrants, measures they have implemented to improve their performance or offer new services and the quality of their relationships with their customers.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is among the world's leading global clinical research organizations. We deliver innovative and robust clinical development solutions -- from first-in-human studies through market launch and surveillance -- to help the world's biopharmaceutical companies maximize product life cycles and grow market share.

Our global clinical development business is focused on five regions -- North America, Europe, Asia/Pacific, Latin America and Africa -- to meet customer needs. We have conducted clinical trials and provided regulatory and pharmacovigilance services in more than 80 countries. The company was named the "Top CRO to Work With" in the Thomson CenterWatch 2007 Survey of U.S. Investigative Sites. Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the company's Web site at http://www.kendle.com.


'/>"/>
SOURCE Kendle International Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Kendle to Ring Opening Bell at NASDAQ Stock Market on August 22
2. Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor Day Event
3. Kendle to Present at Thomas Weisel Partners Healthcare Conference 2007
4. Kendle to Present at Bear Stearns 20th Annual Healthcare Conference
5. Kendle to Present at the UBS Global Life Sciences Conference
6. Kendle to Present at the Natixis Bleichroeder Hidden Gems Conference
7. Kendle Invites You to Attend Its Third Quarter 2007 Earnings Conference Call and Webcast
8. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
9. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
10. Miaxis Biometrics Named as Red Herring 100 Asia Award Winner for 2007
11. Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2016)... ... ... The leading Regenerative Veterinary Medicine Company, VetStem Biopharma ., is proud ... of their own patients with the VetStem Cell Therapy. Each of these veterinarians has ... patients. , The veterinarians are Dr Ross Rich former owner of Cave Creek ...
(Date:5/19/2016)... ... ... Anton Paar USA, located in Ashland, Virginia is pleased to announce that construction ... a third office building to the current facilities. , Growth is nothing new. ... with office space adjacent to the previous main building. Through remodels and new construction, ...
(Date:5/19/2016)... DIEGO , May 19, 2016 ... (OTC PINK: RGBP) and (OTC PINK: RGBPP) announced today ... creating the first cord blood based cancer immunotherapeutic ... provisional patent application, Regen described a generation of ... was potentiated by gene silencing.  The product in ...
(Date:5/18/2016)... , May 18, 2016 The Biotech ... does not mean that there are no opportunities ahead. Today, ... Inc. (NASDAQ: THLD ), Seattle Genetics Inc. (NASDAQ: ... ), and Ophthotech Corp. (NASDAQ: OPHT ). Sign ... at: http://www.activewallst.com/ Threshold Pharmaceuticals ...
Breaking Biology Technology:
(Date:5/9/2016)... -- Elevay is currently known as the ... high net worth professionals seeking travel for work   ... there is still no substitute for a face-to-face meeting. ... deal with a firm handshake. This is why wealthy ... citizenship via investment programs like those offered by the ...
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
Breaking Biology News(10 mins):